Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

Clin Cancer Res. 2004 Jun 1;10(11):3919-26. doi: 10.1158/1078-0432.CCR-03-0787.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor*
  • CA-125 Antigen / biosynthesis*
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Drug Design
  • Drug Evaluation*
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / mortality
  • Prognosis
  • Research Design
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen